(PSEC) Prospect Capital - Overview
Stock: Debt, Equity, Real Estate, Mezzanine, Middle-Market
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 17.63% |
| Yield on Cost 5y | 14.75% |
| Yield CAGR 5y | -8.78% |
| Payout Consistency | 90.7% |
| Payout Ratio | 211.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.3% |
| Relative Tail Risk | -12.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.96 |
| Alpha | -38.76 |
| Character TTM | |
|---|---|
| Beta | 0.760 |
| Beta Downside | 0.930 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.06% |
| CAGR/Max DD | -0.36 |
Description: PSEC Prospect Capital January 15, 2026
Prospect Capital Corporation (NASDAQ:PSEC) is a Business Development Company that targets middle-market companies in the United States and Canada, providing a broad suite of financing solutions-including secured senior debt, unitranche, mezzanine, and equity-across primary origination and secondary loan portfolios. Its investment range is $10 million to $500 million per deal, typically focusing on firms with EBITDA of $5 million-$150 million and diversified exposure across sectors such as energy, industrials, technology, and real estate (particularly multifamily assets).
As of the most recent filing, PSEC reported approximately $11 billion in total assets and a net asset value (NAV) of $15.30 per share, supporting a dividend yield that has hovered around 9%-10% over the past 12 months-an attractive income metric in a low-interest-rate environment. However, the company’s performance is sensitive to credit-market spreads and the pace of private-equity-driven deal flow; a 100-basis-point rise in the 10-year Treasury rate could compress yields on its loan portfolio and pressure the dividend sustainability. Additionally, the ongoing transition toward renewable energy and clean-tech infrastructure is likely to boost deal flow in PSEC’s energy-related segments, given its historical expertise in oil-field services and emerging clean-energy financing.
For a deeper, data-driven view of how these dynamics translate into valuation and risk metrics, you may want to explore the PSEC analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -257.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.93 > 1.0 |
| NWC/Revenue: -58.16% < 20% (prev 19.26%; Δ -77.41% < -1%) |
| CFO/TA 0.02 > 3% & CFO 163.6m > Net Income -257.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (440.3m) vs 12m ago 2.67% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: -1.03% > 50% (prev 2.93%; Δ -3.96% > 0%) |
| Interest Coverage Ratio: 0.48 > 6 (EBITDA TTM -257.9m / Interest Expense TTM 124.4m) |
Altman Z'' 0.38
| A: 0.01 (Total Current Assets 86.5m - Total Current Liabilities 44.0m) / Total Assets 6.64b |
| B: -0.19 (Retained Earnings -1.27b / Total Assets 6.64b) |
| C: 0.01 (EBIT TTM 59.3m / Avg Total Assets 7.12b) |
| D: 0.86 (Book Value of Equity 1.74b / Total Liabilities 2.01b) |
| Altman-Z'' Score: 0.38 = B |
What is the price of PSEC shares?
Over the past week, the price has changed by -4.69%, over one month by -1.03%, over three months by +8.95% and over the past year by -25.71%.
Is PSEC a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the PSEC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.5 | -5.3% |
| Analysts Target Price | 2.5 | -5.3% |
| ValueRay Target Price | 2.9 | 8.7% |
PSEC Fundamental Data Overview February 03, 2026
P/B = 0.4349
P/EG = 1.59
Revenue TTM = -73.2m USD
EBIT TTM = 59.3m USD
EBITDA TTM = -257.9m USD
Long Term Debt = unknown (none)
Short Term Debt = 38.1m USD (from shortTermDebt, last fiscal year)
Debt = 2.09b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -86.5m USD (from netDebt column, last quarter)
Enterprise Value = 3.31b USD (1.30b + Debt 2.09b - CCE 86.5m)
Interest Coverage Ratio = 0.48 (Ebit TTM 59.3m / Interest Expense TTM 124.4m)
EV/FCF = 20.22x (Enterprise Value 3.31b / FCF TTM 163.6m)
FCF Yield = 4.95% (FCF TTM 163.6m / Enterprise Value 3.31b)
WARNING: Negative Revenue TTM = -73.2m
FCF Margin = -223.3% (FCF TTM 163.6m / Revenue TTM -73.2m)
WARNING: Negative Revenue TTM = -73.2m
Net Margin = 352.2% (Net Income TTM -257.9m / Revenue TTM -73.2m)
WARNING: Negative Revenue TTM = -73.2m
Gross Margin = unknown ((Revenue TTM -73.2m - Cost of Revenue TTM 124.4m) / Revenue TTM)
Tobins Q-Ratio = 0.50 (Enterprise Value 3.31b / Total Assets 6.64b)
Interest Expense / Debt = 1.41% (Interest Expense 29.5m / Debt 2.09b)
Taxrate = 21.0% (US default 21%)
NOPAT = 46.9m (EBIT 59.3m * (1 - 21.00%))
Current Ratio = 1.97 (Total Current Assets 86.5m / Total Current Liabilities 44.0m)
Debt / Equity = 0.45 (Debt 2.09b / totalStockholderEquity, last quarter 4.63b)
Debt / EBITDA = 0.34 (negative EBITDA) (Net Debt -86.5m / EBITDA -257.9m)
Debt / FCF = -0.53 (Net Debt -86.5m / FCF TTM 163.6m)
Total Stockholder Equity = 3.58b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.62% (Net Income -257.9m / Total Assets 6.64b)
RoE = -7.21% (Net Income TTM -257.9m / Total Stockholder Equity 3.58b)
RoCE = 0.90% (EBIT 59.3m / Capital Employed (Total Assets 6.64b - Current Liab 44.0m))
RoIC = 0.90% (NOPAT 46.9m / Invested Capital 5.19b)
WACC = 4.04% (E(1.30b)/V(3.39b) * Re(8.72%) + D(2.09b)/V(3.39b) * Rd(1.41%) * (1-Tc(0.21)))
Discount Rate = 8.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.51%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈231.4m ; Y1≈151.9m ; Y5≈69.3m
Fair Price DCF = 4.87 (EV 2.21b - Net Debt -86.5m = Equity 2.29b / Shares 470.9m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -48.64 | EPS CAGR: -10.75% | SUE: -0.49 | # QB: 0
Revenue Correlation: -18.22 | Revenue CAGR: -20.99% | SUE: -0.16 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.10 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-06-30): EPS=0.42 | Chg30d=-0.030 | Revisions Net=-1 | Growth EPS=-45.5% | Growth Revenue=-13.8%
EPS next Year (2027-06-30): EPS=0.38 | Chg30d=-0.040 | Revisions Net=-1 | Growth EPS=-9.5% | Growth Revenue=-1.0%